Works matching IS 22965270 AND DT 2023 AND VI 46
Results: 110
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 1, doi. 10.1159/000535925
- Publication type:
- Article
Contents Vol. 46, 2023.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 548, doi. 10.1159/000535561
- Publication type:
- Article
AbbVie: BioPharma-Unternehmen mit onkologischer Mission.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. I, doi. 10.1159/000535453
- Publication type:
- Article
4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 535, doi. 10.1159/000535447
- Publication type:
- Article
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 533, doi. 10.1159/000535417
- Publication type:
- Article
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. IX, doi. 10.1159/000535408
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 537, doi. 10.1159/000535392
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 538, doi. 10.1159/000535343
- Publication type:
- Article
uGI: Biomaker-Cut-Offs in der Immunonkologie.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 531, doi. 10.1159/000535307
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 543, doi. 10.1159/000535213
- Publication type:
- Article
Selective COX-2 Inhibitor Is Beneficial in Suppressing Chronic Postsurgical Pain in Esophageal Cancer Patients and May Prolong Patient Survival.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 503, doi. 10.1159/000535183
- By:
- Publication type:
- Article
Acknowledgement to Reviewers.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 530, doi. 10.1159/000535159
- Publication type:
- Article
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 520, doi. 10.1159/000535020
- By:
- Publication type:
- Article
Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 12, p. 511, doi. 10.1159/000534856
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 11, p. 1, doi. 10.1159/000535214
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 11, p. 495, doi. 10.1159/000534854
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 11, p. 493, doi. 10.1159/000534771
- Publication type:
- Article
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 11, p. 476, doi. 10.1159/000534674
- By:
- Publication type:
- Article
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 11, p. 459, doi. 10.1159/000534040
- By:
- Publication type:
- Article
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 11, p. 466, doi. 10.1159/000533983
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, p. 1, doi. 10.1159/000534437
- Publication type:
- Article
Prelims.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, p. I, doi. 10.1159/000530186
- Publication type:
- Article
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, p. 1, doi. 10.1159/000533576
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 1, doi. 10.1159/000534508
- Publication type:
- Article
Sacituzumab govitecan: Zulassungserweiterung HR+/HER2– mBC.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 442, doi. 10.1159/000534221
- Publication type:
- Article
Neue AML-Therapie für IDH1-Mutation zugelassen.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 441, doi. 10.1159/000534220
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 444, doi. 10.1159/000534218
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 449, doi. 10.1159/000534144
- Publication type:
- Article
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 433, doi. 10.1159/000533505
- By:
- Publication type:
- Article
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 415, doi. 10.1159/000532042
- By:
- Publication type:
- Article
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 424, doi. 10.1159/000531888
- By:
- Publication type:
- Article
Erratum.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 10, p. 438, doi. 10.1159/000530178
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, p. 1, doi. 10.1159/000534294
- Publication type:
- Article
Prelims.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, p. I, doi. 10.1159/000530839
- Publication type:
- Article
Vorwort des DGHO-Vorstands.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Therapiesteuerung in der Hämatologie und Onkologie.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, p. 2, doi. 10.1159/000533463
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 1, doi. 10.1159/000533996
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 397, doi. 10.1159/000533718
- Publication type:
- Article
CLL-Therapien: Zeitlich begrenzt und zielgerichtet, langfristig erfolgreich.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 392, doi. 10.1159/000533717
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 399, doi. 10.1159/000533682
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 407, doi. 10.1159/000533651
- Publication type:
- Article
Durvalumab-Immuntherapie: Dauer beeinflusste Erfolg.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 390, doi. 10.1159/000533582
- Publication type:
- Article
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 362, doi. 10.1159/000531742
- By:
- Publication type:
- Article
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 370, doi. 10.1159/000531724
- By:
- Publication type:
- Article
OnkoImmun 19.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. I, doi. 10.1159/000531620
- Publication type:
- Article
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 348, doi. 10.1159/000531268
- By:
- Publication type:
- Article
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 382, doi. 10.1159/000530970
- By:
- Publication type:
- Article
Oncology in Europe.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 9, p. 345, doi. 10.1159/000529681
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 7/8, p. 1, doi. 10.1159/000533480
- Publication type:
- Article
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%.
- Published in:
- Oncology Research & Treatment, 2023, v. 46, n. 7/8, p. 340, doi. 10.1159/000533142
- Publication type:
- Article